Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Monahan

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Journal of Virology|March 23, 2000
Kinetics of recombinant adeno-associated virus-mediated gene transferA K Malik, P E Monahan, D L Allen, et al.
Journal of Thrombosis and Haemostasis : JTH|February 19, 2013
IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophiliaN Narkbunnam, J Sun, G Hu, et al.
Blood Reviews|November 13, 2020
Discussing investigational AAV gene therapy with hemophilia patients: A guideRobert F Sidonio, Steven W Pipe, Michael U Callaghan, et al.
Endocrinology|February 11, 1991
Augmented hypothalamic proopiomelanocortin gene expression with pubertal development in the male rat: evidence for an androgen receptor-independent actionJ R Kerrigan, P M Martha, R J Krieg, et al.
Thrombosis and Haemostasis|March 1, 2005
High frequency of premature termination mutations in the factor V gene: three factor V deficiency case reports and a mutation reviewIris Schrijver, Debbie W Hong, Lisa Mandle, et al.
Blood Advances|June 23, 2023
Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia BManfred Schmidt, Graham R Foster, Michiel Coppens, et al.
Journal of Thrombosis and Haemostasis : JTH|July 9, 2009
Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IVT Gui, A Reheman, H Ni, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 7, 2007
Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector doseZhijian Wu, Junjiang Sun, Taiping Zhang, et al.
Blood Advances|March 1, 2021
Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunityJocelyn A Schroeder, Juan Chen, Yingyu Chen, et al.
Journal of Clinical Medicine|January 2, 2020
A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic ArthropathyFeixu Zhang, Mengyang Xu, Qin Yang, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Journal of Virology|March 23, 2000
Kinetics of recombinant adeno-associated virus-mediated gene transferA K Malik, P E Monahan, D L Allen, et al.
Journal of Thrombosis and Haemostasis : JTH|February 19, 2013
IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophiliaN Narkbunnam, J Sun, G Hu, et al.
Blood Reviews|November 13, 2020
Discussing investigational AAV gene therapy with hemophilia patients: A guideRobert F Sidonio, Steven W Pipe, Michael U Callaghan, et al.
Endocrinology|February 11, 1991
Augmented hypothalamic proopiomelanocortin gene expression with pubertal development in the male rat: evidence for an androgen receptor-independent actionJ R Kerrigan, P M Martha, R J Krieg, et al.
Thrombosis and Haemostasis|March 1, 2005
High frequency of premature termination mutations in the factor V gene: three factor V deficiency case reports and a mutation reviewIris Schrijver, Debbie W Hong, Lisa Mandle, et al.
Blood Advances|June 23, 2023
Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia BManfred Schmidt, Graham R Foster, Michiel Coppens, et al.
Journal of Thrombosis and Haemostasis : JTH|July 9, 2009
Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IVT Gui, A Reheman, H Ni, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 7, 2007
Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector doseZhijian Wu, Junjiang Sun, Taiping Zhang, et al.
Blood Advances|March 1, 2021
Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunityJocelyn A Schroeder, Juan Chen, Yingyu Chen, et al.
Journal of Clinical Medicine|January 2, 2020
A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic ArthropathyFeixu Zhang, Mengyang Xu, Qin Yang, et al.
Pageof 13